TABLE 1.

Profile of animals used in this study

Animal ID	Inoculum size	Route of inoculation	Infection	Clinical outcome
H27	4 × 105 TCID50	Intravenous	+	Died at 12.6 wks PIb
H358	4 × 105 TCID50	Intravenous	+	Died at 13.0 wks PI
5980	16,400 TCID50	Intravenous	+	Died at 21.3 wks PI
5981	656 TCID50	Intravenous	+	Died at 23.1 wks PI
6071	25 TCID50	Intravenous	+	Healthy
H520a	25 TCID50	Intravenous	+	Healthy
H521a	5 TCID50	Intravenous	+	Died at 24.1 wks PI
6049	5 TCID50	Intravenous	+	Healthy
6074	1 TCID50	Intravenous	+	Healthy
H431	1 TCID50	Intravenous	−	No infection established
H520a	0.2 TCID50	Intravenous	−	No infection established
H521a	0.04 TCID50	Intravenous	−	No infection established
H704	1 × 105 TCID50 (3 times)	Intravaginal infusion	+	Healthy
903a	1 × 105 TCID50 (3 times)	Intravaginal infusion	−	No infection established
H385	5 × 104 TCID50	Intravaginal infusion	+	Healthy
T14	100 TCID50	Intrarectal injection	+	Died at 12.0 wks PI
903a	100 TCID50	Intrarectal injection	+	Healthy

^aIf no infection was established, this animal was reinoculated with a larger dose or via an alternative route following 24 weeks of observation. 

^bPI, postinfection.